Composition
recombinant human interferon alpha-2b - at least 10,000 IU, di-Medrol - 0.001 g Boric acid - 0.0031 g polyvinylpyrrolidone - 0.01 g polyethylene oxide - 0.05 g Trilon B - 0.0004 g, hypromellose - 0.003 g sodium chloride - 0.004 g of sodium acetate - 0.007 g
Pharmachologic effect
Oftalmoferon has a pronounced therapeutic effect in the treatment of viral diseases of the eye. The product has unique properties associated with the complex composition of eye drops. Human recombinant interferon alfa-2b is completely safe in terms of contamination by viruses gematokontaktnyh infections (hepatitis, CMV, HIV). It has anti-inflammatory, antiproliferativ nym action and provides a pronounced antiviral effect. Diphenhydramine, a part of the droplets provides an anti-histamine, anti-allergic, protivootech-tion effect, it is necessary in acute viral infection of the conjunctiva and cornea. Boric acid has an antibacterial effect, since secondary bacterial infection often associated with viral lesions of the eye. Polymer base eyedrops prolong drug action and function as "artificial tears", eliminating or reducing the need for additional artificial tears instilljatsijah required for viral lesions for treatment and prevention of secondary disorders tear film. Oftalmoferon has a broad spectrum of antiviral activity, anti-inflammatory, immunomodulatory, antimicrobial, local anesthetic and regenerating effect.
Side effects
Oftalmoferon eye tissues is well tolerated and does not cause side effects. Clinical Prizna Cove local toxic or allergic reactions in any case was not registered to the drug. Complaints of patients to irritant effects of the drug were observed.
sale Properties
No prescription
Special conditions
Oftalmoferon was experimental biomedical and clinical research at the Moscow Research Institute of Eye Diseases. Helmholtz. Use of the drug reduces the time of the disappearance of the follicular response when adenoviral conjunctival-vite, leads to the disappearance of edema and hyperemia, it contributes to the rapid regression of subepithelial infiltrates with epidemic keratoconjunctivitis. In the treatment of herpetic keratitis drug Oftalmoferon complete epithelialization of corneal stromal infiltration and resorption was observed in significantly earlier date than using leukocyte interferon derived from human blood.
Indications
- Adenovirus, hemorrhagic (enterovirus), herpetic conjunctivitis;
- Adenovirus, herpes (vesicular, spot, tree, kartoobrazny) keratitis;
- Geperticheskie stromal keratitis with ulceration of the cornea and without expressions;
- Adenovirus and herpes keratokonyuktivity;
- Herpetic uveitis;
- Herpetic keratouveitis (with the expression without it).
Contraindications
Hypersensitivity of the components of the drug, increased intraocular pressure